LY75/DEC-205 抗体
Our Local Distributor
北京 101111
Quick Overview for LY75/DEC-205 抗体 (ABIN7865686)
抗原
See all LY75/DEC-205 (LY75) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- anti-CD205 mouse monoclonal, PN-15, purified
-
纯化方法
- affinity chromatography
-
免疫原
- renal cortical tissue extract
-
亚型
- IgG2b kappa
-
-
-
-
应用备注
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
IHC-paraffin_dilution: 1:25-1:50 (2-4 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:25-1:50 (2-4 μg/mL)
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 100 μg/mL
-
缓冲液
- PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- store at 2 - 8 °C
-
-
- LY75/DEC-205 (LY75) (Lymphocyte Antigen 75 (LY75))
-
别名
- CD205
-
背景
- PN-15 reacts with a lectin receptor like glycoprotein of 200 kDa (gp200), present in proximal renal tubules and on urothelium. The antigen is carbohydrate in nature. Other normal tissues that display the antigen include breast, parathyroid glands, thymus and epididymis. Among renal carcinomas 93 % of primary and 84 % of metastatic carcinomas are positive. Bladder cancers are also largely positive. Other tumor types include breast cancer, teratocarcinomas and parathyroid adenomas. The antigen, also called DEC-205, was assigned to CD205 at CD workshop VII. In the immune system it can facilitate tolerance to self-antigens through uptake of apoptosis derived material by dendritic cells, which in turn present fragments through MHC II and MHC I, either inducing or repressing immune responses, depending on the nature of concomitant signals. Positive control: Renal carcinoma, bladder carcinoma.
抗原
-